Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Lexicon Pharmaceuticals
LXRX
$1.03B
| $2.25M | ﹤0.01% |
187,836
+75,360
| +67% | +$790K |
|
3327
Sarepta Therapeutics
SRPT
$1.68B
| $2.24M | ﹤0.01% |
114,927
+100,042
| +672% | +$1.75M |
|
3328
CALL
iShares MSCI South Korea ETF
EWY
$23.3B
| $2.24M | ﹤0.01% |
42,400
-11,300
| -21% | -$546K |
|
3329
Invesco S&P 500 Top 50 ETF
XLG
$10.8B
| $2.24M | ﹤0.01% |
153,920
+139,140
| +941% | +$1.93M |
|
|
MNDT
3330
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $2.23M | ﹤0.01% |
124,100
-16,900
| -12% | -$275K |
|
3331
PUT
CNX Resources
CNX
$5.33B
| $2.23M | ﹤0.01% |
236,760
-73,920
| -24% | -$537K |
|
3332
Schwab Fundamental US Large Company Index ETF
FNDX
$27B
| $2.23M | ﹤0.01% |
226,692
-30
| -0% | -$278 |
|
3333
CALL
C.H. Robinson
CHRW
$17.2B
| $2.23M | ﹤0.01% |
30,000
+17,600
| +142% | +$1.21M |
|
|
HI
3334
DELISTED
Hillenbrand
HI
| $2.23M | ﹤0.01% |
74,335
-55,683
| -43% | -$1.54M |
|
3335
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$663M
| $2.22M | ﹤0.01% |
57,122
-224,088
| -80% | -$8.1M |
|
|
ZGNX
3336
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $2.22M | ﹤0.01% |
240,000
-260,000
| -52% | -$2.6M |
|
3337
CALL
Ultragenyx Pharmaceutical
RARE
$2.46B
| $2.22M | ﹤0.01% |
35,000
+100
| +0.3% | +$6.54K |
|
3338
RPC Inc
RES
$1.28B
| $2.22M | ﹤0.01% |
156,272
+63,275
| +68% | +$803K |
|
|
WLL
3339
CALL
DELISTED
Whiting Petroleum Corporation
WLL
| $2.21M | ﹤0.01% |
925
+87
| +10% | +$171K |
|
3340
KB Financial Group
KB
$42.2B
| $2.21M | ﹤0.01% |
80,153
-19,110
| -19% | -$488K |
|
|
RPXC
3341
DELISTED
RPX Corporation
RPXC
| $2.21M | ﹤0.01% |
196,129
+72,926
| +59% | +$775K |
|
3342
CALL
Norfolk Southern
NSC
$75.6B
| $2.21M | ﹤0.01% |
26,500
-11,300
| -30% | -$854K |
|
|
TSRO
3343
PUT
DELISTED
TESARO, Inc.
TSRO
| $2.2M | ﹤0.01% |
50,000
-17,500
| -26% | -$702K |
|
3344
PUT
Archer Daniels Midland
ADM
$37.6B
| $2.2M | ﹤0.01% |
60,600
-246,600
| -80% | -$8.58M |
|
|
CLVS
3345
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.2M | ﹤0.01% |
114,600
-17,800
| -13% | -$377K |
|
3346
Hanmi Financial
HAFC
$949M
| $2.19M | ﹤0.01% |
99,560
-26,128
| -21% | -$558K |
|
|
WBC
3347
PUT
DELISTED
WABCO HOLDINGS INC.
WBC
| $2.19M | ﹤0.01% |
+20,500
| New | +$1.94M |
|
3348
Invesco Water Resources ETF
PHO
$2.03B
| $2.19M | ﹤0.01% |
99,711
+1,495
| +2% | +$30.5K |
|
3349
PUT
Emerson Electric
EMR
$86.7B
| $2.19M | ﹤0.01% |
40,200
-747,900
| -95% | -$36.1M |
|
3350
Wayfair
W
$11.8B
| $2.19M | ﹤0.01% |
50,569
+9,595
| +23% | +$397K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.